Compositions and methods for treating proliferative disorders

Details for Australian Patent Application No. 2012202895 (hide)

Owner Universita Di Genova Novo Nordisk A/ S Innate Pharma

Inventors Romagne, Francois; Moretta, Alessandro; Blery, Mathieu; Spee, Petrus Johannes Louis; Morch, Ulrik

Agent Davies Collison Cave

Pub. Number AU-A-2012202895

Parent 2006301163

Filing date 17 May 2012

Wipo publication date 7 June 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202895

7 June 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202896-Process for the production of amides

2012202888-A drum mechanism for an optional free floating shell and non free floating shell.